Artificial intelligence (AI) is transforming emergency medicine at Rambam Health Care Campus (Rambam). In a first-of-its-kind initiative, an AI-powered clinical decision support system is helping physicians in both the adult and pediatric emergency departments identify complex and unusual cases within seconds, support diagnostic precision, and reduce waiting times. As reported in Ynet News, Professor Shahar Shelly, Director of Rambam’s Department of Neurology and Director of

Parents of children with food allergies frequently fear that accidental skin contact with allergenic foods may trigger a severe systemic allergic reaction. Findings from a recent Israeli study offer reassuring, evidence-based guidance that could help ease unnecessary anxiety. A large multicenter Israeli study, led by Dr. Idit Lachover-Roth, Director of the Allergy and Clinical Immunology Unit at Rambam Health Care Campus, aimed to evaluate the risk of systemic allergic reacti

An Israeli-developed technology that uses focused ultrasound to treat enlarged prostate tissue from outside the body is being tested for the first time at Rambam Health Care Campus (Rambam). The technology is intended to offer a non-invasive alternative to conventional invasive procedures that require hospitalization. “Benign enlargement of the prostate—benign prostatic hyperplasia or BPH—is a common and often distressing condition that can cause severe urinary symptoms, incl

A clinical trial conducted at Rambam Health Care Campus has been selected by the Scientific Committee of the European Academy of Neurology (EAN) as one of the five most significant neurology studies of 2025. The trial among the first anywhere to test artificial intelligence in routine neurological practice under randomized controlled conditions produced results that complicate common assumptions about what AI delivers in the clinic. The study was led by Professor Shahar Shell